4G Clinical
4G Clinical, headquartered in the United States, is a pioneering force in the clinical trial industry, specialising in innovative randomisation and trial supply management solutions. Founded in 2015, the company has rapidly established itself as a leader in the field, with a focus on enhancing the efficiency and accuracy of clinical trials across major operational regions, including North America and Europe. The company’s flagship product, 4G Clinical's Randomisation and Trial Supply Management (RTSM) platform, stands out for its user-friendly interface and advanced analytics capabilities, streamlining the complexities of trial logistics. With a commitment to improving patient outcomes and reducing trial timelines, 4G Clinical has achieved significant milestones, positioning itself as a trusted partner for biopharmaceutical companies worldwide.
DitchCarbon Score
How does 4G Clinical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
4G Clinical's score of 3 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
4G Clinical's reported carbon emissions
4G Clinical, headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that 4G Clinical may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. As the industry increasingly prioritises sustainability, it is essential for companies like 4G Clinical to establish clear emissions reduction strategies and set measurable targets to contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
4G Clinical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
